\
&
Contact us
\
&
Contact us
Partnership website: https://www.biodiversa.eu/
The objective of the initiative is to provide an overarching platform connecting national, local and European research and innovation programmes and combining in-cash and in-kind resources in support of one goal - by 2030 biodiversity in Europe is back on a path of recovery.
It co-develops multidisciplinary research and innovation programmes with stakeholders, setting up a European network of harmonised observatories for biodiversity monitoring, providing evidence base for nature-based solutions development and deployment, as well as implementing a broad range of activities to increase the relevance, impact and visibility of EU research and innovation in tackling the biodiversity crisis in line with the EU Biodiversity Strategy for 2030.
Draft partnership proposal (May 2020)
Contact
Commission services: RTD BIODIVERSITY, ENV RESEARCH
Partners: BiodivERsA / FRB - Claire Blery
Belgian Science Policy Office (BELSPO) Hilde Eggermont
Partnerships group the EC and private and/or public partners, to coordinate and streamline the research & innovation initiatives and funding in some selected key domains.
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
